Aastrom & Moll Sign Five-Year Agreement
July 14 2004 - 10:00AM
PR Newswire (US)
Aastrom & Moll Sign Five-Year Agreement DALLAS, July 14
/PRNewswire/ -- Moll Industries, Inc., a medical devices and
components supplier, announced a five-year agreement was reached
with Aastrom Biosciences, Inc. (NASDAQ:ASTM) in first quarter 2004
continuing Moll as sole manufacturer of assembled Cell Cassettes
for the AastromReplicell(R) System, a patented, integrated system
of instrumentation and single-use disposables clinically proven to
produce therapeutic stem and progenitor cell mixtures from sources
such as patient bone marrow. Moll supplies highly complex
comprehensive services to Aastrom, providing complete single-use
final assemblies, which are comprised of approximately 165 parts
that Moll either molds or procures. Moll also manages
sterilization, regularly measures bioburden contamination levels,
handles quarterly dose audits according to AAMI technical
requirements and provides the FDA with certifications for Cassettes
manufactured in Moll's state-of-the-art Class 10,000 Clean Room
facilities in North Carolina. The new contract represents a renewed
commitment that extends appointment of Moll as Aastrom's preferred
supplier since 1996. "Moll has been an exceptional choice as our
partner, supplying expertise in manufacturing and supply chain
management, and providing great value and ability. Our alliance
lets each company do what we do best -- Moll makes Cell Cassettes
for us, and Aastrom focuses on its central mission of delivering
proprietary bone marrow stem cell products for the regenerative
repair of damaged human tissue," said Brian Hampson, Aastrom's Vice
President-Product Development. Commenting on developments, Moll
President Ron Embree stated, "We are proud to support Aastrom, and
to be actively involved in making products that advance the health
of mankind." Aastrom Biosciences, Inc. is currently engaged in
clinical trials both in the U.S. and Europe and markets the
AastromReplicell System. For more information, visit Aastrom's
website at http://www.aastrom.com/ . Moll Industries, Inc. is a
full-service contract manufacturer of custom injection plastic
molding. The company possesses extensive experience manufacturing
Class 1, 2, & 3 Medical Device components and assemblies in
conjunction with Validation & Verification studies, IQ-OQ-PQ
protocols and requirements found in GMP 21 CFR - Part 820. Moll's
operations also include Plasma Treatment and EMABOND(R) processes
that augment core production technologies of value-added assembly,
two-shot, insert molding, post mold decorating and over molding.
For more information, visit Moll's website at
http://www.mollindustries.com/ . DATASOURCE: Moll Industries, Inc.
CONTACT: Dana Gecker of Moll Industries, Inc., +1-972-663-6909, or
Web site: http://www.mollindustries.com/ http://www.aastrom.com/
Copyright
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jul 2023 to Jul 2024